Actively Recruiting
Efficacy of Electroacupuncture Combined With Pregabalin in the Treatment of Trigeminal Herpetic Neuralgia: a Multicenter Randomized Controlled Trial Study Protocol
Led by The Third People's Hospital of Hangzhou · Updated on 2025-02-21
102
Participants Needed
1
Research Sites
97 weeks
Total Duration
On this page
Sponsors
T
The Third People's Hospital of Hangzhou
Lead Sponsor
T
The Third Affiliated hospital of Zhejiang Chinese Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Trigeminal herpetic neuralgia is a common type of Zoster-associated Pain (ZAP), which troubles individuals in all ages and burdens society all over the world. Eleactroaupuncture (EA) is increasingly used in the treatment of ZAP due to its advantages such as low price, high safety, no adverse reactions, and high patient acceptance. Therefore, it is necessary to conduct randomized controlled trials to evaluate the effectiveness and safety of EA on ZAP and whether EA can be used as a substitute for pregabalin.
CONDITIONS
Official Title
Efficacy of Electroacupuncture Combined With Pregabalin in the Treatment of Trigeminal Herpetic Neuralgia: a Multicenter Randomized Controlled Trial Study Protocol
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with trigeminal Zoster-associated Pain lasting 1 to 3 months
- Have a pain score between 4 and 7 on the visual analog scale
- Aged between 18 and 85 years, any gender
- Have clear consciousness and the ability to communicate about pain
- Willing to participate and have signed informed consent
You will not qualify if you...
- Do not meet the above inclusion criteria
- Have herpes zoster on the trunk or limbs, or special types like meningeal or visceral herpes zoster
- Are pregnant or breastfeeding
- Are allergic to pregabalin or acupuncture
- Have severe organ damage, cognitive or mental disorders, aphasia, or other serious illnesses preventing cooperation
- Have severe skin diseases
- Have a pacemaker
- Have participated in other clinical trials within the past 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Hangzhou Third People's Hospital
Hangzhou, Zhejiang, China, 310009
Actively Recruiting
Research Team
P
Pin Lin
CONTACT
C
Chengcheng Kong
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here